Terug
Dagbereik
€ 88,35
€ 91,73
52-Weeksbereik
€ 36,88
€ 109,28
Volume
473.389
50D / 200D Gem.
€ 96,02
/
€ 73,30
Vorige Slotkoers
€ 87,88
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -193,7 | 0,2 |
| P/B | 14,4 | 3,0 |
| ROE % | -8,7 | 3,6 |
| Net Margin % | -4,5 | 3,8 |
| Rev Growth 5Y % | 128,5 | 9,9 |
| D/E | 1,0 | 0,2 |
Koersdoel Analisten
Hold
€ 116,70
+29.4%
Low: € 95,00
High: € 140,00
Forward WPA
-€ 1,62
Omzet Sch.
644,91M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 7,51
€ 6,93 – € 8,01
|
1,58B | 5 |
| FY2029 |
€ 4,85
€ 4,47 – € 5,17
|
1,28B | 2 |
| FY2028 |
€ 1,84
-€ 0,16 – € 4,30
|
994,23M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | € 0,06 | -€ 0,11 | -298,2% |
| 2025-11-04 | -€ 0,10 | € 0,05 | +150,0% |
| 2025-08-06 | -€ 0,31 | -€ 0,12 | +61,3% |
| 2025-05-07 | -€ 0,39 | -€ 0,30 | +23,1% |
| 2025-02-26 | -€ 0,27 | -€ 0,49 | -81,5% |
| 2024-11-12 | -€ 0,45 | -€ 0,30 | +33,3% |
| 2024-08-07 | -€ 0,48 | -€ 0,52 | -8,3% |
| 2024-05-08 | -€ 0,40 | -€ 0,54 | -35,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 128,45% annually over 5 years — strong growth
Generating 54,87M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 73,71%
Capital efficient — spends only 0,18% of revenue on capex
Groei
Revenue Growth (5Y)
128,45%
Revenue (1Y)54,74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-8,65%
ROIC-2,62%
Net Margin-4,48%
Op. Margin-4,25%
Veiligheid
Debt / Equity
1,02
Current Ratio2,67
Interest Coverage-1,54
Waardering
P/E Ratio
-193,74
Forward P/EN/A
P/B Ratio14,38
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 54,74% | Revenue Growth (3Y) | 67,25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 128,45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 521,31M | Net Income (TTM) | -23,36M |
| ROE | -8,65% | ROA | -2,77% |
| Gross Margin | 80,71% | Operating Margin | -4,25% |
| Net Margin | -4,48% | Free Cash Flow (TTM) | 54,87M |
| ROIC | -2,62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,02 | Current Ratio | 2,67 |
| Interest Coverage | -1,54 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -193,74 | Forward P/E | N/A |
| P/B Ratio | 14,38 | P/S Ratio | 8,68 |
| PEG Ratio | 2,28 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 7,02 | Fwd Earnings Yield | N/A |
| FCF Yield | 1,21% | ||
| Market Cap | 4,53B | Enterprise Value | 4,55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 521,31M | 336,89M | 186,37M | 77,06M | 19,14M |
| Net Income | -23,36M | -87,94M | -163,42M | -135,67M | -83,99M |
| EPS (Diluted) | -0,47 | -1,85 | -4,00 | -4,02 | -2,77 |
| Gross Profit | 420,73M | 255,25M | 139,34M | 64,69M | 17,24M |
| Operating Income | -22,14M | -87,61M | -109,15M | -131,22M | -173,41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 842,81M | 670,75M | 646,62M | 352,91M | 294,65M |
| Total Liabilities | 528,12M | 445,11M | 397,95M | 210,87M | 174,44M |
| Shareholders' Equity | 314,69M | 225,64M | 248,67M | 142,04M | 120,21M |
| Total Debt | 319,45M | 317,76M | 308,14M | 2,19M | 2,61M |
| Cash & Equivalents | 296,68M | 222,50M | 286,33M | 28,00M | 31,34M |
| Current Assets | 549,68M | 392,79M | 387,54M | 190,23M | 166,59M |
| Current Liabilities | 205,80M | 126,55M | 87,06M | 64,73M | 42,60M |